基于胞外囊泡的药物传递的端到端分子通讯模型
The End-to-End Molecular Communication Model of Extracellular Vesicle-based Drug Delivery
摘要:
最近,对自然界的更近距离观察使人们对探索和利用由细胞组成的体内通信网络产生了更多的兴趣,这些细胞是内在的、完全生物相容的基础设施,用于提供治疗。天然存在的细胞间通信系统被操纵以释放、导航和摄取可溶性细胞衍生的信使,所述信使本质上是治疗性的或在其结构中携带治疗性分子货物。这种结构的一个例子是细胞外囊泡(EV),最近已被证明具有良好的药代动力学特性,为开发下一代生物治疗开辟了新的途径。在本文中,我们研究的EV传输在心脏组织作为一个案例研究的理论方面,利用信息和通信技术的方法,在分析分子通信系统。我们的建模意味着抽象的EV释放细胞作为发射器,细胞外基质作为通道,和EV接收细胞作为接收器。我们的研究结果,来自发达国家的分析模型,表明,释放可以调制使用外力,如电信号,和传输和接收可以分别受到细胞外基质和质膜性质的影响。结果可以预测EV生物分布,并有助于避免计划外给药,通常会导致副作用和不良反应。
英文摘要:
A closer look at nature has recently brought more interest in exploring and utilizing intra-body communication networks composed of cells as intrinsic, perfectly biocompatible infrastructures to deliver therapeutics. Naturally occurring cell-to-cell communication systems are being manipulated to release, navigate, and take up soluble cell-derived messengers that are either therapeutic by nature or carry therapeutic molecular cargo in their structures. One example of such structures is extracellular vesicles (EVs) which have been recently proven to have favorable pharmacokinetic properties, opening new avenues for developing the next generation biotherapeutics. In this paper, we study theoretical aspects of the EV transfer within heart tissue as a case study by utilizing an information and communication technology-like approach in analyzing molecular communication systems. Our modeling implies the abstraction of the EV releasing cells as transmitters, the extracellular matrix as the channel, and the EV receiving cells as receivers. Our results, derived from the developed analytical models, indicate that the release can be modulated using external forces such as electrical signals, and the transfer and reception can be affected by the extracellular matrix and plasma membrane properties, respectively. The results can predict the EV biodistributions and contribute to avoiding unplanned administration, often resulting in side- and adverse effects.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。